An NYU research team has created ingestible devices called ICOPS (Ingestible Controlled Optogenetic Stimulation) that deliver targeted light stimulation directly to the gut. The technology allows researchers to precisely illuminate specific regions of the intestinal tract, activating specific nerve cells. It could be used to observe how those cells control digestion, for example, and reveal new targets for treating conditions like gastroparesis, where the stomach empties too slowly, or metabolic diseases and eating disorders. 

A nearly $500,000 federal grant was awarded to the University of Cincinnati to establish the Center for Explainable, Ethical, and Trustworthy AI (CEET), a first-of-its-kind hub for humanities-based research and public engagement on the societal dimensions of artificial intelligence.

By custom engineering proteins in the brain, scientists at UC San Diego have shown that addiction can be rewired at the molecular level without negatively impacting enjoyment of normal activities.

This cross-sectional study found that HbA1c levels were associated with the accessibility of modern diabetes technologies and insulin. Efforts to ensure universal accessibility are required to reduce global inequities and glycemic outcomes for children with type 1 diabetes.